For the Inventor, By the Inventor

Enter inventor name

Gainesville, FL, United States of America

Nicholas S Bodor

USPTO Granted Patents = 86

Average Co-Inventor Count = 1.3

ph-index = 24

Forward Citations = 1,677(Granted Patents)

Forward Citations (Not Self Cited) = 1,560(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Lawrence, KS (US) (1978 - 1981)
Gainsville, FL (US) (1991)
Gainesville, FL (US) (1980 - 2009)

Company Filing History:

47 out of 2,930

University of Florida Research Foundation Inc

Interx Research Corporation

Key Pharmaceuticals, Inc.

4. 2 out of 846

Otsuka Pharmaceutical Company, Limited

5. 2 out of 1,829

Schering Corporation

Soft Drugs, Inc.

7. 1 out of 313

8. 1 out of 4,770

Merck + Co., Inc.

9. 1 out of 4,179

Abbott Laboratories Corporation

Intrex Research Corporation

11. 12 out of 832,843

Other

patents

Years Active: 1978-2009

Loading Chart...

Areas of Expertise:

Anti-Inflammatory Steroids

Diabetic Retinopathy

Soft Drug Design

Targeted Drug Delivery

Brain-Specific Drug Delivery

Anticholinergic Compounds

Redox Carriers

Pharmaceutical Formulations

Radionuclides Delivery

Neuroactive Peptides

Transdermal Drug Delivery

Amino Acids

86 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7560448 - Enhancement of activity and/or duration of action of soft anti-inflammatory steroids for topical or other local application (2009-07-14),

2. 7419971 - Enhancement of activity and/or duration of action of selected anti-inflammatory steroids for topical or other local application (2008-09-02),

3. 7115566 - Compounds and method for the prevention and treatment of diabetic retinopathy (2006-10-03),

4. 6943145 - Compounds and method for the prevention and treatment of diabetic retinopathy (2005-09-13),

5. 6610675 - Inactive metabolite approach to soft drug design (2003-08-26),

6. 6440933 - Compounds and method for the prevention and treatment of diabetic retinopathy (2002-08-27),

7. 5981517 - Androstene derivatives (1999-11-09),

8. 5639885 - Redox amino acids and peptides containing them (1997-06-17),

9. 5637601 - Anticholinergic compounds, compositions and methods of treatment (1997-06-10),

10. 5624894 - Brain-enhanced delivery of neuroactive peptides by sequential metabolism (1997-04-29),

11. 5618826 - Anticholinergic compounds, compositions and methods of treatment (1997-04-08),

12. 5618803 - Targeted drug delivery via phosphonate derivatives (1997-04-08),

13. 5610188 - Anticholinergic compounds, compositions and methods of treatment (1997-03-11),

14. 5576332 - Soft .beta.-drenegic blocking agents (1996-11-19),

15. 5525727 - Brain-specific drug delivery (1996-06-11),

Title: The Innovative Journey of Nicholas S Bodor

Introduction: Nicholas S Bodor is a renowned inventor based in Gainesville, FL, known for his groundbreaking contributions to the field of pharmaceuticals and drug delivery systems.

Latest Patents: Nicholas S Bodor holds several patents related to novel drug formulations and delivery methods, revolutionizing the way medications are administered and absorbed by the body.

Career Highlights: With a distinguished career spanning several decades, Nicholas S Bodor has worked tirelessly to develop innovative solutions for enhancing the effectiveness of pharmaceuticals, earning him recognition as a pioneer in the industry.

Collaborations: Throughout his career, Nicholas S Bodor has collaborated with leading researchers, pharmaceutical companies, and academic institutions to further advance the field of drug development and delivery, resulting in numerous successful partnerships and groundbreaking discoveries.

Conclusion: Nicholas S Bodor's relentless pursuit of innovation and his dedication to improving drug delivery systems have cemented his legacy as a visionary inventor in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…